|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| |||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) | ||
| 1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Restricted Stock Unit (1) | (2) | 02/13/2018 | A | 3,640 | (3) | (4) | Common Stock | 3,640 | $ 73.24 | 16,277.1559 (5) | D | ||||
| Stock Option (6) | (7) | 02/13/2018 | A | 13,142 | (8) | (9) | Common Stock | 13,142 | $ 0 | 84,473 (7) | D | ||||
| Performance Award Unit (10) | (11) | 02/13/2018 | A | 3,237.3036 | (12) | (4) | Common Stock | 3,237.3036 | $ 0 | 3,237.3036 | D | ||||
| Reporting Owner Name / Address | Relationships | |||
| Director | 10% Owner | Officer | Other | |
| Trawicki Roman C/O ZOETIS INC. 10 SYLVAN WAY PARSIPPANY, NJ 07054 |
Executive Vice President | |||
| /s/ Katherine H. Walden, as Attorney-in-Fact | 02/15/2018 | |
| **Signature of Reporting Person | Date |
| * | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
| ** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| (1) | Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. |
| (2) | Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. |
| (3) | Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. |
| (4) | Not applicable. |
| (5) | The RSUs vest as follows: 2,217.8497 RSUs will vest on February 27, 2018; 1,298.3327 RSUs will vest on July 21, 2018; 4,851.9141 RSUs will vest on February 19, 2019; 4,269.0594 RSUs will vest on February 14, 2020; and 3,640 RSUs will vest on February 13, 2021. |
| (6) | Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. |
| (7) | 23,885 options granted January 30, 2015 at an exercise price of $42.73 per option; 8,568 options granted February 27, 2015 at an exercise price of $46.09 per option; 4,688 options granted July 21, 2015 at an exercise price of $49.12 per option; 17,873 options granted February 19, 2016 at an exercise price of $41.83 per option; 16,317 options granted February 14, 2017 at an exercise price of $55.02 per option; and 13,142 options granted February 13, 2018 at an exercise price of $73.24 per option. |
| (8) | Each option vests on the third anniversary of the date of grant. |
| (9) | Each option expires on the tenth anniversary of the date of grant. |
| (10) | Represents performance award units with a three-year performance period covering 2015-2017 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 13, 2018, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 27, 2018, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. |
| (11) | Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. |
| (12) | Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 27, 2018, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. |